MetaStat, Inc. to Present at SeeThruEquity Fall Microcap Investor Conference in New York City

BOSTON–(BUSINESS WIRE)– MetaStat,
Inc. (OTCQB:MTST),
a pre-commercial biotechnology company focused on the development and
commercialization of diagnostic tests that are prognostic for risk of
cancer metastasis, companion diagnostics to predict drug response, and
anti-metastatic drugs, announced today that it has been invited to
present at the upcoming SeeThruEquity Fall Microcap Investor Conference.
The conference will be held on October 17, 2016 at the Convene Grand
Central located at 101 Park Avenue – 1st Floor. MetaStat will be
presenting on Monday, October 17, 2016 at 1:00 pm (ET) at the Madison
Hub.

Douglas A. Hamilton, MetaStat’s Chief Executive Officer, will present an
overview of the company and its growth strategy during the presentation.

About MetaStat, Inc.

We are a pre-commercial biotechnology company focused on the development
and commercialization of diagnostic tests that are prognostic for risk
of cancer metastasis, companion diagnostics to predict drug response,
and anti-metastatic drugs. Our driver-based platform technology is based
on the pivotal role of the Mena protein and its isoforms, a common
pathway for the development of metastatic disease in epithelial-based
solid tumors.

Our product development strategy is based on identifying patients most
at risk for cancer metastasis and targeting the underlying mechanisms
that drive the metastatic cascade. Unlike most oncology therapeutics
that kill cancer cells directly or inhibit cancer cell proliferation, we
focus on preventing aggressive tumors from spreading. This is
particularly relevant as most cancer deaths are caused by aggressive
tumors that spread throughout the body and not due to growth of the
primary tumor.

Forward-Looking Statements

This press release contains « forward-looking statements » within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended, and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995. You
are cautioned that such statements are subject to a multitude of risks
and uncertainties that could cause future circumstances, events or
results to differ materially from those projected in the forward-looking
statements as a result of various factors and other risks, including
those set forth in the Company’s Form 10-K filed with the Securities and
Exchange Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue reliance
on such statements. The forward-looking statements in this release are
made as of the date hereof and the company undertakes no obligation to
update such statements.

Image may be NSFW.
Clik here to view.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161017005711/en/